Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-Guided L2 Level QLESP Block for Postoperative Analgesia in Robot-Assisted Partial Nephrectomy
NCT07704970Recruiting
- Sponsor
- Huazhong University of Science and Technology
- Start
- Sep 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by Huazhong University of Science and Technology. Primary endpoint: Cumulative Opioid Consumption at 48 Hours Postoperatively. Started Sep 2026; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07704970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07704970.